ERAMET EO 305 ADR 1/10 (ER70) - Total Liabilities
Based on the latest financial reports, ERAMET EO 305 ADR 1/10 (ER70) has total liabilities worth €4.39 Billion EUR (≈ $5.13 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ERAMET EO 305 ADR 1/10 (ER70) cash flow conversion to assess how effectively this company generates cash.
ERAMET EO 305 ADR 1/10 - Total Liabilities Trend (2022–2025)
This chart illustrates how ERAMET EO 305 ADR 1/10's total liabilities have evolved over time, based on quarterly financial data. For the full company profile including market capitalisation, see ERAMET EO 305 ADR 1/10 (ER70) total market value.
ERAMET EO 305 ADR 1/10 Competitors by Total Liabilities
The table below lists competitors of ERAMET EO 305 ADR 1/10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Biohaven Pharmaceutical Holding Co Ltd
NYSE:BHVN
|
USA | $399.38 Million |
|
Shunsin Technology Holdings Ltd
TW:6451
|
Taiwan | NT$12.08 Billion |
|
Jiangsu Zijin Rural Commercial Bank Co Ltd
SHG:601860
|
China | CN¥265.61 Billion |
|
Eurocommercial Properties N.V.
AS:ECMPA
|
Netherlands | €1.90 Billion |
|
Huapont Life Sciences Co Ltd
SHE:002004
|
China | CN¥13.15 Billion |
|
Xinyu Iron & Steel Co Ltd
SHG:600782
|
China | CN¥21.63 Billion |
|
FAP Agri Tbk PT
JK:FAPA
|
Indonesia | Rp6.13 Trillion |
|
Amore Group
KO:002790
|
Korea | ₩1.39 Trillion |
Liability Composition Analysis (2022–2025)
This chart breaks down ERAMET EO 305 ADR 1/10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ERAMET EO 305 ADR 1/10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ERAMET EO 305 ADR 1/10 (2022–2025)
The table below shows the annual total liabilities of ERAMET EO 305 ADR 1/10 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €4.39 Billion ≈ $5.13 Billion |
+1.41% |
| 2024-12-31 | €4.33 Billion ≈ $5.06 Billion |
+1.00% |
| 2023-12-31 | €4.28 Billion ≈ $5.01 Billion |
-12.86% |
| 2022-12-31 | €4.91 Billion ≈ $5.74 Billion |
-- |
About ERAMET EO 305 ADR 1/10
ERAMET S.A. produces and sells manganese and nickel metals in Asia, Europe, North America, and internationally. It extracts and processes manganese and nickel ores; extracts and develops mineral sands; and mines and processes lithium deposits. The company also offers manganese alloys, including silicomanganese, low-carbon silicomanganese, and manganese dioxide, as well as medium, low, and high ca… Read more